Pennant Group (DB:1ZU) - Aandelenkoers, Nieuws & Analyse

1ZU Overzicht aandelen

The Pennant Group, Inc. levert diensten in de gezondheidszorg in de Verenigde Staten.

1ZU fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	4/6
Prestaties in het verleden	5/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Verhandeld tegen 19.7% onder onze schatting van de reële waarde

De winst zal naar verwachting met 26.56% per jaar groeien

De winst groeide het afgelopen jaar met 49.2%

Risicoanalyse

Heeft een hoog schuldenniveau

Aandeelhouders zijn het afgelopen jaar verwaterd

The Pennant Group, Inc. Concurrenten

SYNLAB

HMSE:SYAB

€2.5b

Fresenius Medical Care

XTRA:FME

€10.4b

Fresenius SE KGaA

XTRA:FRE

€18.7b

RHÖN-KLINIKUM

XTRA:RHK

€863.5m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Pennant Group
Historische aandelenkoersen
Huidige aandelenkoers	US$31.20
52 Week Hoogtepunt	US$33.00
52 Week Laag	US$10.00
Bèta	2.01
11 maand verandering	-0.64%
3 maanden verandering	11.43%
1 Jaar Verandering	205.88%
33 jaar verandering	65.96%
5 jaar verandering	75.68%
Verandering sinds IPO	96.20%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	1ZU	DE Healthcare	DE Markt
7D	0%	-3.0%	-1.0%
1Y	205.9%	26.3%	16.1%

Rendement versus industrie: 1ZU overtrof de German Healthcare industrie, die het afgelopen jaar een rendement 26.3 % opleverde.

Rendement versus markt: 1ZU overtrof de German markt, die het afgelopen jaar een rendement opleverde van 16.1 %.

Prijsvolatiliteit

Is 1ZU's price volatile compared to industry and market?
1ZU volatility
1ZU Average Weekly Movement	6.3%
Healthcare Industry Average Movement	3.8%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: 1ZU heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van 1ZU is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2019	5,791	Brent Guerisoli	www.pennantgroup.com

The Pennant Group, Inc. levert diensten in de gezondheidszorg in de Verenigde Staten. Het bedrijf is actief in twee segmenten, Home Health and Hospice Services en Senior Living Services. Het bedrijf biedt thuiszorgdiensten aan, waaronder klinische diensten, zoals verpleging, logopedie, ergotherapie en fysiotherapie, medisch maatschappelijk werk en thuiszorgdiensten; en hospicediensten, waaronder klinische zorg, onderwijs en adviesdiensten voor de fysieke, spirituele en psychosociale behoeften van terminaal zieke patiënten en hun families.

The Pennant Group, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Pennant Group zich tot de beurswaarde?
1ZU fundamentele statistieken
Marktkapitalisatie	€1.07b
Inkomsten(TTM)	€17.80m
Inkomsten(TTM)	€563.35m

59.1x

Koers/Winstverhouding

1.9x

P/S-verhouding

Is 1ZU overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1ZU resultatenrekening (TTM)
Inkomsten	US$611.81m
Kosten van inkomsten	US$482.48m
Brutowinst	US$129.33m
Overige uitgaven	US$110.00m
Inkomsten	US$19.33m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 06, 2024

Winst per aandeel (EPS)	0.56
Brutomarge	21.14%
Nettowinstmarge	3.16%
Schuld/Eigen Vermogen Verhouding	47.5%

Hoe presteerde 1ZU op de lange termijn?

Bekijk historische prestaties en vergelijking

1ZU Overzicht aandelen

Beloningen

Risicoanalyse

The Pennant Group, Inc. Concurrenten

HMSE:SYAB

€2.5b

XTRA:FME

€10.4b

XTRA:FRE

€18.7b

XTRA:RHK

€863.5m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Now 21% undervalued

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

New minor risk - Shareholder dilution

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

Recent updates

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Now 21% undervalued

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

New minor risk - Shareholder dilution

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

Second quarter 2024 earnings released: EPS: US$0.19 (vs US$0.094 in 2Q 2023)

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.062 in 1Q 2023)

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

The Pennant Group, Inc. Provides Revenue Guidance for 2024

Full year 2023 earnings released: EPS: US$0.45 (vs US$0.23 in FY 2022)

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.17 in 3Q 2022)

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Second quarter 2023 earnings released: EPS: US$0.094 (vs US$0.094 loss in 2Q 2022)

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Investor sentiment improves as stock rises 16%

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

First quarter 2023 earnings released: EPS: US$0.062 (vs US$0.035 in 1Q 2022)

Investor sentiment improves as stock rises 24%

Independent Chairman recently bought €63k worth of stock

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: US$0.23 (vs US$0.095 in FY 2021)

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought €196k worth of stock

The Pennant Group, Inc. Announces Resignation of Derek Bunker,Chief Investment Officer, Executive Vice President and Corporate Secretary, Effective December 31, 2022

Third quarter 2022 earnings released: EPS: US$0.17 (vs US$0.044 in 3Q 2021)

The Pennant Group, Inc. Provides Earnings Guidance for the Year 2022

The Pennant Group, Inc. to Report Q3, 2022 Results on Nov 07, 2022

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Kenosha Visiting Nurse Association, Inc.

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Ardent Hospice and Palliative Care.

The Pennant Group, Inc. Reaffirms Revenue Guidance for the Full Year 2022

Second quarter 2022 earnings released: US$0.094 loss per share (vs US$0.093 profit in 2Q 2021)

The Pennant Group, Inc. to Report Q2, 2022 Results on Aug 08, 2022

The Pennant Group, Inc. Announces Resignation of Mr. Daniel Walker as Chief Executive Officer, Effective on August 1, 2022

The Pennant Group, Inc. to Appoint John Gochnour as President and Chief Operating Officer

First quarter 2022 earnings released: EPS: US$0.035 (vs US$0.034 in 1Q 2021)

The Pennant Group, Inc. Provides Revenue Guidance for the Full Year 2022

The Pennant Group, Inc. to Report Q1, 2022 Results on May 09, 2022

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired First Choice Home Health.

Non-Independent Director recently bought €417k worth of stock

The Pennant Group, Inc., Annual General Meeting, Jun 01, 2022

The Pennant Group, Inc. Revises Earnings Guidance for the Full Year of 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improved over the past week

The Pennant Group, Inc. to Report Q4, 2021 Results on Feb 28, 2022